Cambridge, UK and Indianapolis, US – 27 February 2020: Acacia Pharma Group plc (“Acacia Pharma” or the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialization of…Original Article
FDA Approves Barhemsys (amisulpride) for the Treatment and Prevention of PONV
